Correlation Between Vertex Pharmaceuticals and Fast Retailing

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Vertex Pharmaceuticals and Fast Retailing at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Vertex Pharmaceuticals and Fast Retailing into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Vertex Pharmaceuticals Incorporated and Fast Retailing Co, you can compare the effects of market volatilities on Vertex Pharmaceuticals and Fast Retailing and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Vertex Pharmaceuticals with a short position of Fast Retailing. Check out your portfolio center. Please also check ongoing floating volatility patterns of Vertex Pharmaceuticals and Fast Retailing.

Diversification Opportunities for Vertex Pharmaceuticals and Fast Retailing

0.02
  Correlation Coefficient

Significant diversification

The 3 months correlation between Vertex and Fast is 0.02. Overlapping area represents the amount of risk that can be diversified away by holding Vertex Pharmaceuticals Incorpo and Fast Retailing Co in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Fast Retailing and Vertex Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Vertex Pharmaceuticals Incorporated are associated (or correlated) with Fast Retailing. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Fast Retailing has no effect on the direction of Vertex Pharmaceuticals i.e., Vertex Pharmaceuticals and Fast Retailing go up and down completely randomly.

Pair Corralation between Vertex Pharmaceuticals and Fast Retailing

Assuming the 90 days horizon Vertex Pharmaceuticals is expected to generate 1.9 times less return on investment than Fast Retailing. But when comparing it to its historical volatility, Vertex Pharmaceuticals Incorporated is 1.09 times less risky than Fast Retailing. It trades about 0.05 of its potential returns per unit of risk. Fast Retailing Co is currently generating about 0.08 of returns per unit of risk over similar time horizon. If you would invest  29,540  in Fast Retailing Co on September 20, 2024 and sell it today you would earn a total of  2,690  from holding Fast Retailing Co or generate 9.11% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Vertex Pharmaceuticals Incorpo  vs.  Fast Retailing Co

 Performance 
       Timeline  
Vertex Pharmaceuticals 

Risk-Adjusted Performance

3 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in Vertex Pharmaceuticals Incorporated are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. Despite nearly stable basic indicators, Vertex Pharmaceuticals is not utilizing all of its potentials. The latest stock price disturbance, may contribute to mid-run losses for the stockholders.
Fast Retailing 

Risk-Adjusted Performance

6 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in Fast Retailing Co are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. In spite of rather fragile basic indicators, Fast Retailing may actually be approaching a critical reversion point that can send shares even higher in January 2025.

Vertex Pharmaceuticals and Fast Retailing Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Vertex Pharmaceuticals and Fast Retailing

The main advantage of trading using opposite Vertex Pharmaceuticals and Fast Retailing positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Vertex Pharmaceuticals position performs unexpectedly, Fast Retailing can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Fast Retailing will offset losses from the drop in Fast Retailing's long position.
The idea behind Vertex Pharmaceuticals Incorporated and Fast Retailing Co pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.

Other Complementary Tools

Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance